Liberator Medical Supply revenue was $81.60 m in FY, 2015 which is a 9.4% year over year increase from the previous period.
Founding Date | 1906 |
Total Funding | $7 m |
USD | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|
Revenue | 69.1k | 74.6m | 81.6m |
Revenue growth, % | 8% | 9% | |
Cost of goods sold | 25.7k | 27.8m | 31.5m |
Gross profit | 43.4k | 46.8m | 50.1m |
Gross profit Margin, % | 63% | 63% | 61% |
Sales and marketing expense | 8.9k | 11.2m | |
General and administrative expense | 4.7k | 6.0m | |
Operating expense total | 31.7k | 38.1m | |
Depreciation and amortization | 683.0 | 525.0k | |
EBIT | 11.8k | 12.7m | 11.9m |
EBIT margin, % | 17% | 17% | 15% |
Interest expense | 83.0 | 50.0k | |
Pre tax profit | 11.7k | 12.7m | 11.9m |
Income tax expense | 4.6k | 4.9m | 4.6m |
Net Income | 7.1k | 7.8m | 7.3m |
USD | Q2, 2014 | Q3, 2014 | Q3, 2015 |
---|---|---|---|
Revenue | 17.6k | 18.6m | 20.4m |
Cost of goods sold | 6.6k | 6.8m | 7.9m |
Gross profit | 11.0k | 11.8m | 12.5m |
Gross profit Margin, % | 62% | 63% | 61% |
Sales and marketing expense | 2.4k | 2.6m | 2.9m |
General and administrative expense | 1.4k | 1.4m | 1.5m |
Operating expense total | 8.4k | 8.6m | 10.1m |
Depreciation and amortization | 168.0 | 166.0k | 137.0k |
EBIT | 2.6k | 3.1m | 2.4m |
EBIT margin, % | 15% | 17% | 12% |
Pre tax profit | 2.6k | 3.1m | 2.3m |
Income tax expense | 971.0 | 1.1m | 671.0k |
Net Income | 1.6k | 2.0m | 1.7m |
USD | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|
Cash | 12.5k | 12.3m | 9.4m |
Accounts Receivable | |||
Inventories | |||
Current Assets | 24.8k | 25.5m | 29.6m |
Total Assets | 49.1k | 54.3m | 62.6m |
Accounts Payable | 4.9k | 6.1m | 9.9m |
Dividends Payable | 1.6k | 1.7m | 1.7m |
Short-term debt | |||
Current Liabilities | 9.1k | 9.9m | 16.5m |
Long-term debt | |||
Total Debt | |||
Total Liabilities | 19.3k | 28.9m | |
Additional Paid-in Capital | 35.1k | 36.4m | 37.3m |
Retained Earnings | (4.9k) | (3.5m) | (3.2m) |
Total Equity | 29.8k | 32.4m | 33.7m |
Financial Leverage | 1.6 x | 1.7 x | 1.9 x |
USD | Q2, 2014 | Q3, 2014 | Q3, 2015 |
---|---|---|---|
Cash | 9.6k | 10.3m | 9.1m |
Current Assets | 24.7k | 24.4m | 25.2m |
Total Assets | 51.2k | 51.6m | 57.3m |
Accounts Payable | 5.7k | 5.1m | 5.5m |
Dividends Payable | 1.6k | 1.6m | 1.7m |
Current Liabilities | 9.1k | 8.7m | 11.9m |
Total Liabilities | 20.0k | 19.8m | 23.6m |
Additional Paid-in Capital | 36.0k | 36.2m | 37.0m |
Retained Earnings | (4.3k) | (3.9m) | (2.9m) |
Total Equity | 31.3k | 31.9m | 33.7m |
Financial Leverage | 1.6 x | 1.6 x | 1.7 x |
USD | FY, 2013 | FY, 2014 | FY, 2015 |
---|---|---|---|
Net Income | 7.1k | 7.8m | 7.3m |
Depreciation and Amortization | 683.0 | 663.0k | 11.6m |
Accounts Receivable | (4.5m) | (5.9m) | |
Inventories | 255.0k | (4.3m) | |
Accounts Payable | 1.2m | 3.8m | |
Cash From Investing Activities | (360.0k) | ||
Dividends Paid | (2.6k) | (6.3m) | (6.9m) |
Cash From Financing Activities | (5.4m) | ||
Interest Paid | 84.0 | 51.0k | 63.0k |
Income Taxes Paid | 171.0 | 4.2m | 3.1m |